Aortic constriction is a rare congenital cardiovascular malformation, first discovered in 1760, accounting for 5% to 8% of congenital heart disease, mostly seen in males, the disease is more aggressive, the average natural life expectancy of patients with simple aortic constriction is only 40 years. The only previous treatment for these patients is surgery, which involves resection of the vessel at the site of narrowing after opening the chest, end-to-end suturing of the vessel or artificial vessel anastomosis, which is risky and has a high mortality rate, with a mortality rate of 10% for two operations for restenosis, and is prone to postoperative complications. This operation using the new aortic narrowing overlapping stent has the effect of intravascular dilatation of the stenotic segment and endothelial covering of the torn piece, which can effectively prevent complications such as endothelial rupture and aneurysm formation. As a new treatment technology, only a few large hospitals in China are able to perform the procedure, and the number of cases that can be performed each year is quite limited due to the difficulty and high risk of the procedure and the high precision required during the operation. In order to ensure the successful completion of this interventional procedure, Prof. Yushun Zhang carefully analyzed the condition before surgery, formulated a strict surgical plan, and successfully performed the overlapping stent placement for the patient. After the operation, the patient’s blood pressure returned to normal and he recovered well, making the operation a complete success. This technique fills the gap of this type of surgery in the northwest region, provides a simple and safe treatment for patients with aortic constriction, and also accumulates valuable experience for similar surgeries in the future.